Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

Authors: Jonathan O'B Hourihane, Kirsten Beyer, Allyah Abbas, Montserrat Fernández-Rivas, Paul J Turner, Katharina Blumchen, Caroline Nilsson, Maria D Ibáñez, Antoine Deschildre, Antonella Muraro, Vibha Sharma, Michel Erlewyn-Lajeunesse, José Manuel Zubeldia, Frederic De Blay, Christine D Sauvage, Aideen Byrne, John Chapman, Franck Boralevi, Audrey DunnGalvin, Charmaine O'Neill, David Norval, Andrea Vereda, Ben Skeel, Daniel C Adelman, George du Toit

Published: 2020-07-20

DOI: 10.1016/s2352-4642(20)30234-0

Source: Full article

---

Abstract

No abstract found.